U.S., E.U. Agree on Mutual Recognition of Drug Manufacturing Inspections By Anna Jurczynska | March 13, 2017 Posted in Recent News and tagged Drug Manufacturing Inspections, EU, U.S., U.S.-EU Mutual Recognition Agreement ← CORE PROFESSIONAL COMPETENCE SURVEYFDA Proposes Eight-Month Review of Priority Generics, Plans for Wave of Biosimilars →